Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01138436 · ClinicalTrials.gov registry record · Phase 2
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
A Phase 2 study, sponsored by Skingenix.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT01138436 is a Phase 2 study that has completed, run by Skingenix. The registered enrollment target is 5 participants.
The verdict
NCT01138436, a Phase 2 study, has completed, sponsored by Skingenix.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a Phase II, randomized, controlled, two-center pilot study designed to assess the safety and efficacy of MEBO in the treatment of 14 subjects with VLUs. Subjects meeting entry criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of treatment with either MEBO or SOC (7 subjects per treatment arm).
Interventions
- PROCEDURE Standard of Care
- DRUG MEBO Wound Ointment (MEBO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01138436
The ClinicalTrials.gov registry entry for NCT01138436 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Skingenix, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT01138436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01138436 about?
NCT01138436 is a clinical study titled "A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers". This is a Phase II, randomized, controlled, two-center pilot study designed to assess the safety and efficacy of MEBO in the treatment of 14 subjects with VLUs. Subjects meeting entry criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of treatment with either MEBO or SOC (7 subjects...
What is the current status of trial NCT01138436?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2010-11. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01138436?
The interventions under investigation include: Standard of Care (PROCEDURE), MEBO Wound Ointment (MEBO) (DRUG).
Who is sponsoring clinical trial NCT01138436?
This trial is sponsored by Skingenix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.